Acute myelocytic leukaemia associated with Kaposi's sarcoma in a patient without serum antibodies to human immunodeficiency virus type 1

British Journal of Dermatology

Volumn 134, Issue 3, 1996, Pages 551-553

  Hernandez D E ^a,b   Pellino, M L ^a   Ramirez B ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b NONE   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL;

EID: 0029985720     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb16248.x     Document Type: Article

References (5)

1. Martin RW III, Hood AF, Farmer ER. Kaposi sarcoma. Medicine (Baltimore) 1993; 72: 245-61.
2. Qunibi W, Akhtar M, Sheth K et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84: 225-32.
3. Safai B, Mikie V, Giraldo G et al. Association of Kaposi's sarcoma with second primary malignancies. Possible etiopathogenic implications. Cancer 1980; 45: 1472-9.
4. Stribling J, Weitzner S, Smith GV. Kaposi's sarcoma in renal allograft recipients. Cancer 1978; 42: 442-6.
5. Sinkovics JG. Kaposi's sarcoma: its oncogenes and growth factors. Crit Rev Oncol Hematol 1991; 11: 87-107.